{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T15:06:40Z","timestamp":1791990400202,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Athenaeum Dietrich Goetze Stiftung fuer Kultur und Wissenschaft Health + Life Science Alliance Heidelberg Mannheim"},{"DOI":"10.13039\/501100005973","name":"Dr. Mildred Scheel Stiftung f\u00fcr Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>T-ALL relapses are characterized by chemotherapy resistance, cellular diversity and dismal outcome. To gain a deeper understanding of the mechanisms underlying relapses, we conduct single-cell RNA sequencing on 13 matched pediatric T-ALL patient-derived samples at diagnosis and relapse, along with samples derived from 5 non-relapsing patients collected at diagnosis. This comprehensive longitudinal single-cell study in T-ALL reveals significant transcriptomic diversity. Notably, 11 out of 18 samples exhibit a subpopulation of T-ALL cells with stem-like features characterized by a common set of active regulons, expression patterns and splice isoforms. This subpopulation, accounting for a small proportion of leukemia cells at diagnosis, expands substantially at relapse, indicating resistance to therapy. Strikingly, increased stemness at diagnosis is associated with higher risk of treatment induction failure. Chemotherapy resistance is validated through in-vitro and in-vivo drug testing. Thus, we report the discovery of treatment-resistant stem-like cells in T-ALL, underscoring the potential for devising future therapeutic strategies targeting stemness-related pathways.<\/jats:p>","DOI":"10.1038\/s41467-025-61222-1","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T08:40:52Z","timestamp":1751013652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of stem-like cells in chemotherapy resistance and relapse in pediatric T-cell acute lymphoblastic leukemia"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7942-4495","authenticated-orcid":false,"given":"Julia","family":"Costea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin K.","family":"Rauwolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2428-7618","authenticated-orcid":false,"given":"Pietro","family":"Zafferani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5773-5620","authenticated-orcid":false,"given":"Tobias","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4617-7015","authenticated-orcid":false,"given":"Anna","family":"Mathioudaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8324-4040","authenticated-orcid":false,"given":"Judith","family":"Zaugg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schrappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1039-2872","authenticated-orcid":false,"given":"Cornelia","family":"Eckert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Escherich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6571-6227","authenticated-orcid":false,"given":"Jean P.","family":"Bourquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-3191","authenticated-orcid":false,"given":"Beat","family":"Bornhauser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1953-0848","authenticated-orcid":false,"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-3794","authenticated-orcid":false,"given":"Jan O.","family":"Korbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,27]]},"reference":[{"key":"61222_CR1","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1200\/JCO.2003.10.116","volume":"21","author":"JM Goldberg","year":"2003","unstructured":"Goldberg, J. M. et al. Childhood T-cell acute lymphoblastic leukemia: the dana-farber cancer institute acute lymphoblastic leukemia consortium experience. J. Clin. Oncol. 21, 3616\u20133622 (2003).","journal-title":"J. Clin. Oncol."},{"key":"61222_CR2","doi-asserted-by":"publisher","first-page":"4502","DOI":"10.3390\/ijms22094502","volume":"22","author":"MW Lato","year":"2021","unstructured":"Lato, M. W., Przysucha, A., Grosman, S., Zawitkowska, J. & Lejman, M. The new therapeutic strategies in pediatric T-cell acute lymphoblastic leukemia. Int. J. Mol. Sci. 22, 4502 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"61222_CR3","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1200\/JCO.1997.15.6.2214","volume":"15","author":"FM Uckun","year":"1997","unstructured":"Uckun, F. M. et al. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children\u2019s Cancer Group study. J. Clin. Oncol. 15, 2214\u20132221 (1997).","journal-title":"J. Clin. Oncol."},{"key":"61222_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","volume":"1","author":"AA Ferrando","year":"2002","unstructured":"Ferrando, A. A. et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 1, 75\u201387 (2002).","journal-title":"Cancer Cell"},{"key":"61222_CR5","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3324\/haematol.2015.129692","volume":"100","author":"JB Kunz","year":"2015","unstructured":"Kunz, J. B. et al. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation. Haematologica 100, 1442\u20131450 (2015).","journal-title":"Haematologica"},{"key":"61222_CR6","doi-asserted-by":"publisher","first-page":"11306","DOI":"10.1073\/pnas.1608420113","volume":"113","author":"K Oshima","year":"2016","unstructured":"Oshima, K. et al. Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc. Natl. Acad. Sci. USA 113, 11306\u201311311 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61222_CR7","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41375-022-01587-0","volume":"36","author":"P Richter-Pecha\u0144ska","year":"2022","unstructured":"Richter-Pecha\u0144ska, P. et al. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution. Leukemia 36, 1759\u20131768 (2022).","journal-title":"Leukemia"},{"key":"61222_CR8","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1172\/JCI61269","volume":"122","author":"P Van Vlierberghe","year":"2012","unstructured":"Van Vlierberghe, P. & Ferrando, A. The molecular basis of T cell acute lymphoblastic leukemia. J. Clin. Invest. 122, 3398\u20133406 (2012).","journal-title":"J. Clin. Invest."},{"key":"61222_CR9","doi-asserted-by":"publisher","first-page":"58728","DOI":"10.18632\/oncotarget.11233","volume":"7","author":"BD Yadav","year":"2016","unstructured":"Yadav, B. D. et al. Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia. Oncotarget 7, 58728\u201358742 (2016).","journal-title":"Oncotarget"},{"key":"61222_CR10","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nature09727","volume":"471","author":"CG Mullighan","year":"2011","unstructured":"Mullighan, C. G. et al. CREBBP mutations in relapsed acute lymphoblastic leukaemia. Nature 471, 235\u2013239 (2011).","journal-title":"Nature"},{"key":"61222_CR11","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1084\/jem.20180570","volume":"215","author":"IM Ari\u00ebs","year":"2018","unstructured":"Ari\u00ebs, I. M. et al. PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia. J. Exp. Med. 215, 3094\u20133114 (2018).","journal-title":"J. Exp. Med."},{"key":"61222_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1080\/17474086.2020.1685866","volume":"13","author":"M Bloom","year":"2020","unstructured":"Bloom, M., Maciaszek, J. L., Clark, M. E., Pui, C.-H. & Nichols, K. E. Recent advances in genetic predisposition to pediatric acute lymphoblastic leukemia. Expert Rev. Hematol. 13, 55\u201370 (2020).","journal-title":"Expert Rev. Hematol."},{"key":"61222_CR13","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1038\/s41587-022-01361-8","volume":"40","author":"F Salmen","year":"2022","unstructured":"Salmen, F. et al. High-throughput total RNA sequencing in single cells using VASA-seq. Nat. Biotechnol. 40, 1780\u20131793 (2022).","journal-title":"Nat. Biotechnol."},{"key":"61222_CR14","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1038\/nmeth.4463","volume":"14","author":"S Aibar","year":"2017","unstructured":"Aibar, S. et al. SCENIC: single-cell regulatory network inference and clustering. Nat. Methods 14, 1083\u20131086 (2017).","journal-title":"Nat. Methods"},{"key":"61222_CR15","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s41596-020-0336-2","volume":"15","author":"B Van De Sande","year":"2020","unstructured":"Van De Sande, B. et al. A scalable SCENIC workflow for single-cell gene regulatory network analysis. Nat. Protoc. 15, 2247\u20132276 (2020).","journal-title":"Nat. Protoc."},{"key":"61222_CR16","doi-asserted-by":"publisher","first-page":"eaay3224","DOI":"10.1126\/science.aay3224","volume":"367","author":"J-E Park","year":"2020","unstructured":"Park, J.-E. et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 367, eaay3224 (2020).","journal-title":"Science"},{"key":"61222_CR17","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"61222_CR18","doi-asserted-by":"publisher","first-page":"9229","DOI":"10.1073\/pnas.1318731111","volume":"111","author":"A Okhrimenko","year":"2014","unstructured":"Okhrimenko, A. et al. Human memory T cells from the bone marrow are resting and maintain long-lasting systemic memory. Proc. Natl. Acad. Sci. USA 111, 9229\u20139234 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61222_CR19","doi-asserted-by":"publisher","first-page":"btac757","DOI":"10.1093\/bioinformatics\/btac757","volume":"39","author":"Z Fang","year":"2023","unstructured":"Fang, Z., Liu, X. & Peltz, G. GSEApy: a comprehensive package for performing gene set enrichment analysis in Python. Bioinformatics 39, btac757 (2023).","journal-title":"Bioinformatics"},{"key":"61222_CR20","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61222_CR21","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267\u2013273 (2003).","journal-title":"Nat. Genet."},{"key":"61222_CR22","doi-asserted-by":"publisher","unstructured":"O\u2019Connor, K. W. et al. The role of quiescent thymic progenitors in TAL\/LMO2-induced T-ALL chemotolerance. Leukemia https:\/\/doi.org\/10.1038\/s41375-024-02232-8 (2024).","DOI":"10.1038\/s41375-024-02232-8"},{"key":"61222_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.exphem.2018.09.006","volume":"69","author":"D Senft","year":"2019","unstructured":"Senft, D. & Jeremias, I. A rare subgroup of leukemia stem cells harbors relapse-inducing potential in acute lymphoblastic leukemia. Exp. Hematol. 69, 1\u201310 (2019).","journal-title":"Exp. Hematol."},{"key":"61222_CR24","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","volume":"632","author":"P P\u00f6l\u00f6nen","year":"2024","unstructured":"P\u00f6l\u00f6nen, P. et al. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia. Nature 632, 1082\u20131091 (2024).","journal-title":"Nature"},{"key":"61222_CR25","doi-asserted-by":"publisher","first-page":"112804","DOI":"10.1016\/j.celrep.2023.112804","volume":"42","author":"CS Park","year":"2023","unstructured":"Park, C. S. et al. Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia. Cell Rep. 42, 112804 (2023).","journal-title":"Cell Rep."},{"key":"61222_CR26","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.3390\/cancers2041838","volume":"2","author":"NR Dos Santos","year":"2010","unstructured":"Dos Santos, N. R., Ghezzo, M. N., Da Silva, R. C. & Fernandes, M. T. NF-\u03baB in T-cell acute lymphoblastic leukemia: oncogenic functions in leukemic and in microenvironmental cells. Cancers 2, 1838\u20131860 (2010).","journal-title":"Cancers"},{"key":"61222_CR27","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay0524","volume":"367","author":"MA ElTanbouly","year":"2020","unstructured":"ElTanbouly, M. A. et al. VISTA is a checkpoint regulator for na\u00efve T cell quiescence and peripheral tolerance. Science 367, eaay0524 (2020).","journal-title":"Science"},{"key":"61222_CR28","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/ng.3283","volume":"47","author":"SW Paugh","year":"2015","unstructured":"Paugh, S. W. et al. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells. Nat. Genet. 47, 607\u2013614 (2015).","journal-title":"Nat. Genet."},{"key":"61222_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/s41416-018-0014-0","volume":"118","author":"R Bortolozzi","year":"2018","unstructured":"Bortolozzi, R. et al. AKR1C enzymes sustain therapy resistance in paediatric T-ALL. Br. J. Cancer 118, 985\u2013994 (2018).","journal-title":"Br. J. Cancer"},{"key":"61222_CR30","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1172\/JCI92981","volume":"128","author":"M Garc\u00eda-Peydr\u00f3","year":"2018","unstructured":"Garc\u00eda-Peydr\u00f3, M. et al. The NOTCH1\/CD44 axis drives pathogenesis in a T cell acute lymphoblastic leukemia model. J. Clin. Invest. 128, 2802\u20132818 (2018).","journal-title":"J. Clin. Invest."},{"key":"61222_CR31","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","volume":"117","author":"E Coustan-Smith","year":"2011","unstructured":"Coustan-Smith, E. et al. New markers for minimal residual disease detection in acute lymphoblastic leukemia. Blood 117, 6267\u20136276 (2011).","journal-title":"Blood"},{"key":"61222_CR32","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1182\/blood-2003-09-3243","volume":"103","author":"S Chiaretti","year":"2004","unstructured":"Chiaretti, S. et al. Gene expression profile of adult T-cell acute lymphocytic leukemia identifies distinct subsets of patients with different response to therapy and survival. Blood 103, 2771\u20132778 (2004).","journal-title":"Blood"},{"key":"61222_CR33","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1309\/AJCPS1K0OHLJYWWV","volume":"133","author":"H Shao","year":"2010","unstructured":"Shao, H. et al. Minimal residual disease detection by flow cytometry in adult T-cell leukemia\/lymphoma. Am. J. Clin. Pathol. 133, 592\u2013601 (2010).","journal-title":"Am. J. Clin. Pathol."},{"key":"61222_CR34","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.1182\/blood-2011-04-345595","volume":"118","author":"LE Hogan","year":"2011","unstructured":"Hogan, L. E. et al. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies. Blood 118, 5218\u20135226 (2011).","journal-title":"Blood"},{"key":"61222_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3103-1","volume":"17","author":"Y-P Chow","year":"2017","unstructured":"Chow, Y.-P., Alias, H. & Jamal, R. Meta-analysis of gene expression in relapsed childhood B-acute lymphoblastic leukemia. BMC Cancer 17, 120 (2017).","journal-title":"BMC Cancer"},{"key":"61222_CR36","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1126\/science.277.5334.1986","volume":"277","author":"CT Kuo","year":"1997","unstructured":"Kuo, C. T., Veselits, M. L. & Leiden, J. M. LKLF: a transcriptional regulator of single-positive T cell quiescence and survival. Science 277, 1986\u20131990 (1997).","journal-title":"Science"},{"key":"61222_CR37","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/90633","volume":"2","author":"AF Buckley","year":"2001","unstructured":"Buckley, A. F., Kuo, C. T. & Leiden, J. M. Transcription factor LKLF is sufficient to program T cell quiescence via a c-Myc\u2013dependent pathway. Nat. Immunol. 2, 698\u2013704 (2001).","journal-title":"Nat. Immunol."},{"key":"61222_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ni1565","volume":"9","author":"E Sebzda","year":"2008","unstructured":"Sebzda, E., Zou, Z., Lee, J. S., Wang, T. & Kahn, M. L. Transcription factor KLF2 regulates the migration of naive T cells by restricting chemokine receptor expression patterns. Nat. Immunol. 9, 292\u2013300 (2008).","journal-title":"Nat. Immunol."},{"key":"61222_CR39","doi-asserted-by":"publisher","first-page":"100962","DOI":"10.1016\/j.xcrm.2023.100962","volume":"4","author":"I Van Der Werf","year":"2023","unstructured":"Van Der Werf, I. et al. Detection and targeting of splicing deregulation in pediatric acute myeloid leukemia stem cells. Cell Rep. Med. 4, 100962 (2023).","journal-title":"Cell Rep. Med."},{"key":"61222_CR40","doi-asserted-by":"publisher","unstructured":"Black, K. L. et al. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Acids Res. https:\/\/doi.org\/10.1093\/nar\/gky946 (2018).","DOI":"10.1093\/nar\/gky946"},{"key":"61222_CR41","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","volume":"5","author":"E Sotillo","year":"2015","unstructured":"Sotillo, E. et al. Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 5, 1282\u20131295 (2015).","journal-title":"Cancer Discov."},{"key":"61222_CR42","doi-asserted-by":"crossref","unstructured":"ICGC PedBrain-Seq Project, et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321\u2013327 (2018).","DOI":"10.1038\/nature25480"},{"key":"61222_CR43","doi-asserted-by":"publisher","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","volume":"52","author":"PW Harrison","year":"2024","unstructured":"Harrison, P. W. et al. Ensembl 2024. Nucleic Acids Res. 52, D891\u2013D899 (2024).","journal-title":"Nucleic Acids Res."},{"key":"61222_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/ng1403","volume":"36","author":"JA Holbrook","year":"2004","unstructured":"Holbrook, J. A., Neu-Yilik, G., Hentze, M. W. & Kulozik, A. E. Nonsense-mediated decay approaches the clinic. Nat. Genet. 36, 801\u2013808 (2004).","journal-title":"Nat. Genet."},{"key":"61222_CR45","doi-asserted-by":"publisher","first-page":"108656","DOI":"10.1016\/j.celrep.2020.108656","volume":"34","author":"AE Almada","year":"2021","unstructured":"Almada, A. E. et al. FOS licenses early events in stem cell activation driving skeletal muscle regeneration. Cell Rep. 34, 108656 (2021).","journal-title":"Cell Rep."},{"key":"61222_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41586-020-2968-3","volume":"588","author":"AK Jayavelu","year":"2020","unstructured":"Jayavelu, A. K. et al. Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms. Nature 588, 157\u2013163 (2020).","journal-title":"Nature"},{"key":"61222_CR47","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.3324\/haematol.2017.167502","volume":"103","author":"L Trentin","year":"2018","unstructured":"Trentin, L. et al. Leukemia reconstitution in vivo is driven by cells in early cell cycle and low metabolic state. Haematologica 103, 1008\u20131017 (2018).","journal-title":"Haematologica"},{"key":"61222_CR48","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fonc.2017.00218","volume":"7","author":"SH Tan","year":"2017","unstructured":"Tan, S. H., Bertulfo, F. C. & Sanda, T. Leukemia-initiating cells in T-cell acute lymphoblastic leukemia. Front. Oncol. 7, 218 (2017).","journal-title":"Front. Oncol."},{"key":"61222_CR49","doi-asserted-by":"publisher","first-page":"4165","DOI":"10.1158\/0008-5472.CAN-20-2571","volume":"81","author":"F Tamiro","year":"2021","unstructured":"Tamiro, F., Weng, A. P. & Giambra, V. Targeting leukemia-initiating cells in acute lymphoblastic leukemia. Cancer Res. 81, 4165\u20134173 (2021).","journal-title":"Cancer Res."},{"key":"61222_CR50","doi-asserted-by":"publisher","first-page":"e9443","DOI":"10.15252\/emmm.201809443","volume":"10","author":"P Richter-Pecha\u0144ska","year":"2018","unstructured":"Richter-Pecha\u0144ska, P., et al. PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemia. EMBO Mol. Med. 10, e9443 (2018).","journal-title":"EMBO Mol. Med."},{"key":"61222_CR51","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1182\/blood-2010-11-320309","volume":"118","author":"M Schmitz","year":"2011","unstructured":"Schmitz, M. et al. Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment. Blood 118, 1854\u20131864 (2011).","journal-title":"Blood"},{"key":"61222_CR52","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1093\/bioinformatics\/bts480","volume":"28","author":"J K\u00f6ster","year":"2012","unstructured":"K\u00f6ster, J. & Rahmann, S. Snakemake\u2014a scalable bioinformatics workflow engine. Bioinformatics 28, 2520\u20132522 (2012).","journal-title":"Bioinformatics"},{"key":"61222_CR53","doi-asserted-by":"publisher","unstructured":"Zafferani, P. Zaffe24\/AS_VASAseq_sc_pipeline: v1.0. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15512143 (2024).","DOI":"10.5281\/zenodo.15512143"},{"key":"61222_CR54","doi-asserted-by":"publisher","unstructured":"Zafferani, P., Rausch, T. & jcostea. Zaffe24\/Costea-et-al.\u22122024: v1.0.0. Zenodo https:\/\/doi.org\/10.5281\/zenodo.15514411 (2025).","DOI":"10.5281\/zenodo.15514411"},{"key":"61222_CR55","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1182\/blood.2023021815","volume":"143","author":"A Mathioudaki","year":"2024","unstructured":"Mathioudaki, A. et al. The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature. Blood 143, 1269\u20131281 (2024).","journal-title":"Blood"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61222-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61222-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T10:02:52Z","timestamp":1751018572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61222-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61222"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61222-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.24.600391","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,27]]},"assertion":[{"value":"16 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5413"}}